Company Jounce Therapeutics, Inc.
Equities
JNCE
US4811161011
Biotechnology & Medical Research
Business Summary
Number of employees: 141
Managers
Managers | Title | Age | Since |
---|---|---|---|
Kevin Tang
CEO | Chief Executive Officer | 57 | - |
Michael Hearne
DFI | Director of Finance/CFO | - | - |
Eric Laub
IRC | Investor Relations Contact | - | 31/08/21 |
Allison Nance
LAW | General Counsel | - | 30/04/16 |
Ted Harding
HRO | Human Resources Officer | - | - |
General Counsel | - | 16/09/19 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Kevin Tang
CEO | Chief Executive Officer | 57 | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 52,635,468 | 41,318,605 ( 78.50 %) | 0 | 78.50 % |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.73B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |